about
Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort.The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi.Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study.The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE).Absence of Basal Cell Carcinoma in Irradiated Childhood Cancer Survivors of Black Race: A Report from the St. Jude Lifetime Cohort StudyThe cost and cost-effectiveness of childhood cancer treatment in El Salvador, Central America: A report from the Childhood Cancer 2030 Network.Opportunities for expanding clinical trial enrollment for relapsed and refractory pediatric acute myeloid leukemia in the United States and Canada.Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study.Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease StudyThe management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?Surveillance for Late Effects in Childhood Cancer SurvivorsThe global burden of childhood cancer: Knowing what we do not knowLate effects of childhood cancer - Authors' replyChronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort StudyCurrent and coming challenges in the management of the survivorship populationGlobal Access to Essential Medicines for Childhood Cancer: A Cross-Sectional SurveyDeterminants and Consequences of Financial Hardship Among Adult Survivors of Childhood Cancer: A Report From the St. Jude Lifetime Cohort StudyChildhood cancer burden: a review of global estimatesThe Toronto Guidelines: a practical means for childhood cancer stagingGlobal efforts toward the cure of childhood acute lymphoblastic leukaemiaLifestyle factors and health-related quality of life in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort StudyEvidence From Ghana Indicates That Childhood Cancer Treatment in Sub-Saharan Africa Is Very Cost Effective: A Report From the Childhood Cancer 2030 NetworkEstimating the total incidence of global childhood cancer: a simulation-based analysisBuilding the financial case for treating childhood cancer in resource-limited settingsClinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime CohortCost-benefit analysis of implementing a pediatric early warning system at a pediatric oncology hospital in a low-middle income country
P50
Q30239868-EBEC8282-5E85-4EA8-A8AC-1C5811ECEC49Q38412219-44110193-317E-4BD5-8DFB-8EB111C9D811Q38836695-B0498D04-A5E9-461A-8EB8-09A872970C2CQ39176676-E26E5DD1-0D6D-4D14-9B6C-02D2E3B08319Q40048832-95BC5DEC-F78E-46D2-A88B-9F55057B2F0EQ40661649-72E8B492-4129-4C4F-B134-89E7C8832069Q40672544-1D0F9C45-224A-4202-8ACC-62015484F5B0Q42690896-A24DE612-FB1E-4428-AECB-A510CC7A229DQ48137679-471B49B2-198C-430A-B73E-57400BE2DF6EQ49788370-C6FBA819-D6DE-4775-99BB-A59AB125BCA8Q56669882-42EABD64-1517-4A5E-8080-8CFBBC1BE651Q57174504-68A77CC5-6167-49DB-8D75-A017FE51B642Q57175266-8B0D2478-F7D5-42CE-8E0E-F794B080BC78Q87835342-CCBFA133-CD22-4815-91A8-E0DA3FCFAD9BQ88607475-2D666A56-69FC-409A-84A6-BE79C9EDF649Q89777552-2C8B949C-8EC1-4FF2-9F67-012894BF91BEQ90529207-7627D685-F8E9-482E-9F2B-8DD2A99741FAQ90735469-ADFD34C3-85ED-46FE-B7C2-6C9DE3A3D1E3Q90808569-629EB849-9281-47A7-B0F2-8345DAA783EFQ90916349-4DDF29E8-C184-4576-8612-5329305555C3Q91248914-22117E40-EFDB-4E19-9BA5-E2B0A86933EBQ91249010-26FCA945-58C8-48E5-9405-FFCB84E9942EQ91381935-AAAF528F-D8B6-4721-B664-544174AE35E2Q91630525-242B0D17-8AAC-42FC-B20A-530839037E5AQ92057792-EBDA9E9A-FA84-4CD1-8B35-2582855AFFB5Q92165070-63ECEBF6-116E-4ED1-889C-83D5800502ECQ92554207-1EE9D3BC-EC40-47E1-A7E0-D7E2C1E9C7A5Q92766745-3302E8DE-4CA8-415A-8789-534EEE69F9C7
P50
description
researcher ORCID ID = 0000-0001-5282-7833
@en
wetenschapper
@nl
name
Nickhill Bhakta
@ast
Nickhill Bhakta
@en
Nickhill Bhakta
@es
Nickhill Bhakta
@nl
type
label
Nickhill Bhakta
@ast
Nickhill Bhakta
@en
Nickhill Bhakta
@es
Nickhill Bhakta
@nl
prefLabel
Nickhill Bhakta
@ast
Nickhill Bhakta
@en
Nickhill Bhakta
@es
Nickhill Bhakta
@nl
P31
P496
0000-0001-5282-7833